Related Experiment Video
Updated: Jun 1, 2026

Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain
Published on: May 10, 2017
Neuromodulation for intractable OAB
12nd Department of Urology, Aristotle University of Thessaloniki, Thessaloniki, Greece. zefxis@yahoo.co.uk
Sacral neuromodulation (SNM) effectively treats overactive bladder (OAB) symptoms short- and long-term. Further research is needed to optimize patient selection, understand SNM
Area of Science:
- Urology
- Neuromodulation
- Pelvic Floor Disorders
Background:
- Intractable overactive bladder (OAB) significantly impacts quality of life.
- Sacral neuromodulation (SNM) is a recognized second-line treatment option for OAB.
- Current understanding of SNM's long-term effects and mechanisms requires further investigation.
Purpose of the Study:
- To comprehensively review the current evidence on sacral neuromodulation (SNM) for intractable overactive bladder (OAB).
- To evaluate SNM's efficacy, technical aspects, adverse events, and cost-effectiveness.
- To identify areas for future research in SNM for OAB treatment.
Main Methods:
- Systematic literature review of PubMed English-language publications.
- Analysis of studies focusing on efficacy, technical issues, alternative techniques, mechanism of action, adverse events, and cost-effectiveness.
- Inclusion of randomized controlled trials and observational studies on SNM for OAB.
Main Results:
- SNM demonstrates significant short- and long-term efficacy in managing urgency incontinence and other OAB symptoms.
- Technical advancements have improved outcomes and reduced complications, but revision rates remain high.
- The precise mechanism of action is not fully understood, potentially involving spinal reflex and cortical activity modulation.
Conclusions:
- Current evidence supports SNM's efficacy for intractable OAB.
- Further research is essential to refine patient selection, identify prognostic factors, elucidate the mechanism of action, and minimize complications.
- Less invasive SNM techniques may provide viable alternatives.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
